跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMAZYRE pemigatinib 9 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PEMAZYRE pemigatinib 9 mg tablet blister pack
Approved
STANDARD
PEMAZYRE pemigatinib 9 mg tablet blister pack
Specialised Therapeutics Alim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
54dcd74c0a5f085f
Company
Specialised Therapeutics Alim Pty Ltd
Type
Standard
Approval Details
Approval Id
54dcd74c0a5f085f
Product Name
PEMAZYRE pemigatinib 9 mg tablet blister pack
Artg Id
373031
Artg Name
PEMAZYRE pemigatinib 9 mg tablet blister pack
Sponsor
Specialised Therapeutics Alim Pty Ltd
Company Detail Path
/organization/specialised-therapeutics-alim-pty-ltd
Artg Date
2022-09-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
REP
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/32a93cdf9068d0e3b8da9f394f2ac542.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/db3d793ed614b62e0d4514bb45855cbe.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
54dcd74c0a5f085f
Type
Standard
Back to TGA Approvals